西藏药业: 西藏诺迪康药业股份有限公司第八届监事会第十次会议决议公告

Meeting Details - The 10th meeting of the 8th Supervisory Board of the company was held on August 14, 2025, in Chengdu, with all three supervisors present [1] - The meeting was conducted in accordance with the Company Law and the Articles of Association [1] Resolutions Passed - The Supervisory Board unanimously approved the 2025 semi-annual report, confirming its compliance with relevant laws and regulations [1] - The board also approved the 2025 semi-annual profit distribution plan [2] - A proposal to cancel the Supervisory Board and amend the Articles of Association will be submitted for shareholder meeting approval [2]